Johnson & Johnson’s consumer health spinoff, Kenvue, was valued at $40 billion ahead of its initial public offering, The Wall Street Journal reported April 23.
Read the full post on Becker's Hospital Review - Healthcare News
J&J consumer health spinoff valued at $40B
